[HTML][HTML] Uptake of hepatitis C direct-acting antiviral treatment in China: a retrospective study from 2017 to 2021
X Du, J Mi, H Cheng, Y Song, Y Li, J Sun… - Infectious Diseases of …, 2023 - Springer
Abstract Background Direct-acting antivirals (DAAs) for hepatitis C treatment in China
became available since 2017. This study expects to generate evidence to inform decision …
became available since 2017. This study expects to generate evidence to inform decision …
[HTML][HTML] Unblocking barriers of access to hepatitis C treatment in China: lessons learned from Tianjin
P Zhang, R Guo, J Lian, M Zhi, C Lu, W Wu… - Annals of Global …, 2020 - ncbi.nlm.nih.gov
Background: The high price is a critical barrier of access to new direct-anting-antiviral (DAA)
therapies for hepatitis C for both the patients and the society. Many countries continue to …
therapies for hepatitis C for both the patients and the society. Many countries continue to …
[HTML][HTML] Current treatment status and barriers for patients with chronic HCV infection in mainland China: a national multicenter cross-sectional survey in 56 hospitals
DD Bian, HY Zhou, S Liu, M Liu, C Duan, JY Zhang… - Medicine, 2017 - journals.lww.com
Chronic hepatitis C virus (HCV) infection is a serious public health problem worldwide.
China, as the country with the largest number of HCV infections in the world, plays a …
China, as the country with the largest number of HCV infections in the world, plays a …
[HTML][HTML] Pathways to ensure universal and affordable access to hepatitis C treatment
Direct-acting antivirals (DAAs) have dramatically changed the landscape of hepatitis C
treatment and prevention. The World Health Organization has called for the elimination of …
treatment and prevention. The World Health Organization has called for the elimination of …
[HTML][HTML] Economic and epidemiological evaluation of interventions to reduce the burden of hepatitis C in Yunnan province, China
A Heffernan, Y Ma, S Nayagam, P Chan, Z Chen… - PLoS …, 2021 - journals.plos.org
Background The paradigm shift in hepatitis C virus (HCV) treatment options in the last five
years has raised the prospect of eliminating the disease as a global health threat. This will …
years has raised the prospect of eliminating the disease as a global health threat. This will …
[HTML][HTML] Estimating the price at which hepatitis C treatment with direct-acting antivirals would be cost-saving in Japan
Abstract In Japan, 1.5–2 million people are chronically infected with hepatitis C virus (HCV)
infection. New direct-acting antiviral agents (DAA) offer an unprecedented opportunity to …
infection. New direct-acting antiviral agents (DAA) offer an unprecedented opportunity to …
[PDF][PDF] Treatment coverage and drug expenditure in hepatitis C patients from 2013 to 2019: a journey of improving treatment accessibility in Malaysia through …
HK Chan, MA Hassali, RM Said, MRA Hassan - Hepatitis Monthly, 2020 - brieflands.com
Background: Hepatitis C is a public health threat, affecting approximately 1.9% of the
Malaysian population. Objectives: This study demonstrates how a series of initiatives taken …
Malaysian population. Objectives: This study demonstrates how a series of initiatives taken …
How would China achieve WHO's target of eliminating HCV by 2030?
M Li, H Zhuang, L Wei - Expert review of anti-infective therapy, 2019 - Taylor & Francis
ABSTRACT Introduction: Hepatitis C virus (HCV) infection is a major global health concern
on the rise, prompting unprecedented efforts by the World Health Organization (WHO) to …
on the rise, prompting unprecedented efforts by the World Health Organization (WHO) to …
Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antivirals
Background Patients co-infected with HIV and hepatitis C virus (HCV) are a priority target for
HCV treatment. The simplicity and efficacy of direct-acting antivirals (DAA) should help …
HCV treatment. The simplicity and efficacy of direct-acting antivirals (DAA) should help …
[HTML][HTML] Eliminate hepatitis C as a public health threat: a narrative review of strategies, gaps, and opportunities for China
Y Song, Y Li, H Cheng, X Du, J Mi, LV Le… - Infectious Diseases and …, 2022 - Springer
Introduction As a country that is heavily burdened by hepatitis C, China's successful
responses to this public health threat have significant implications for the achievement of the …
responses to this public health threat have significant implications for the achievement of the …